Table 2.
Clinical characteristics of the study population
| Total | Non-obese | Obese | P-value | |
|---|---|---|---|---|
| (n = 320) | (n = 156) | (n = 164) | ||
| Age (year) | 43 ± 13 | 43 ± 15 | 44 ± 11 | 0.38 |
| Body mass index (kg/m2) | 25 ± 5 | 20 ± 2 | 30 ± 3 | < 0.001 |
| Weight (kg) | 68 ± 14 | 57 ± 8 | 78 ± 11 | < 0.001 |
| Height (cm) | 163 ± 9 | 165 ± 9 | 161 ± 9 | < 0.001 |
| Hip circumference (cm) | 98 ± 10 | 90 ± 5 | 106 ± 8 | < 0.001 |
| Waist circumference (cm) | 87 ± 13 | 76 ± 8 | 97 ± 9 | < 0.001 |
| Waist to hip | 0.89 ± 0.08 | 0.81 ± 0.007 | 0.91 ± 0.004 | < 0.001 |
| Triglyceride (mg/dL) | 140 ± 72 | 113 ± 61 | 165 ± 72 | < 0.001 |
| Total cholesterol (mg/dl) | 188 ± 41 | 174 ± 39 | 201 ± 39 | < 0.001 |
| High density lipoprotein cholesterol (mg/dl) | 39 ± 10 | 40 ± 9 | 39 ± 10 | 0.15 |
| Low density lipoprotein cholesterol (mg/dl) | 120 ± 33 | 111 ± 35 | 128 ± 34 | < 0.001 |
| Systolic blood pressure (mm Hg) | 113 ± 13 | 109 ± 13 | 117 ± 12 | < 0.001 |
| Diastolic blood pressure (mm Hg) | 72 ± 8 | 70 ± 9 | 75 ± 7 | < 0.001 |
| Cortisol | 11 ± 61 | 13 ± 7 | 10 ± 6 | 0.002 |
| Adiponectin | 6.5 ± 58 | 7.8 ± 58 | 6.2 ± 57 | 0.015 |
| FBS (mg/dL) | 91 ± 22 | 87 ± 15 | 96 ± 27 | < 0.001 |
Difference between mean level, were analyzed by ANOVA for normally distributed variables and kruskal-Wallis test for variables with a skewed distribution